Abstract
Due to the high number of cardiovascular disease deaths (CVD) there is an eminent search for new biomarkers that may aid in the diagnosis of diseases. Currently, in addition to diagnostic imaging, clinical evaluation is restricted to the evaluation of troponin and natriuretic peptide levels in biofluids. In this sense, the metabolomics (untageted or targeted) has been presented as a poten…